MatchMiner: an open-source platform for cancer precision medicine. NPJ Precis Oncol. 2022 Oct 06; 6(1):69.
View in:
PubMed
Histiocytosis. Lancet. 2021 07 10; 398(10295):157-170.
View in:
PubMed
Genomic Characterization of de novo Metastatic Breast Cancer. Clin Cancer Res. 2021 02 15; 27(4):1105-1118.
View in:
PubMed
The coming of age of Langerhans cell histiocytosis. Nat Immunol. 2020 01; 21(1):1-7.
View in:
PubMed
BRAF V600E and Pten deletion in mice produces a histiocytic disorder with features of Langerhans cell histiocytosis. PLoS One. 2019; 14(9):e0222400.
View in:
PubMed
Langerhans cell histiocytosis: progress and controversies. Br J Haematol. 2019 12; 187(5):559-562.
View in:
PubMed
American Association for Cancer Research Project Genomics Evidence Neoplasia Information Exchange: From Inception to First Data Release and Beyond-Lessons Learned and Member Institutions' Perspectives. JCO Clin Cancer Inform. 2018 12; 2:1-14.
View in:
PubMed
Histiocytoses: emerging neoplasia behind inflammation. Lancet Oncol. 2017 02; 18(2):e113-e125.
View in:
PubMed
Institutional implementation of clinical tumor profiling on an unselected cancer population. JCI Insight. 2016 11 17; 1(19):e87062.
View in:
PubMed
CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice. PLoS One. 2016; 11(11):e0165595.
View in:
PubMed
Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci. Pediatr Blood Cancer. 2016 10; 63(10):1704-12.
View in:
PubMed
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016 06 02; 127(22):2672-81.
View in:
PubMed
Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality. JAMA Oncol. 2015 Oct; 1(7):879-80.
View in:
PubMed
Genomic Alterations in Langerhans Cell Histiocytosis. Hematol Oncol Clin North Am. 2015 Oct; 29(5):839-51.
View in:
PubMed
Congenital and Acquired Disorders of Macrophages and Histiocytes. Hematol Oncol Clin North Am. 2015 Oct; 29(5):i.
View in:
PubMed
Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder. Transl Psychiatry. 2015 Sep 15; 5:e636.
View in:
PubMed
Dedication. Hematol Oncol Clin North Am. 2015 Oct; 29(5):xi-xii.
View in:
PubMed
Congenital and Acquired Disorders of Macrophages and Histiocytes. Hematol Oncol Clin North Am. 2015 Oct; 29(5):xiii-xv.
View in:
PubMed
Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study. Pediatr Blood Cancer. 2015 Dec; 62(12):2162-6.
View in:
PubMed
MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis. Genes Chromosomes Cancer. 2015 Jun; 54(6):361-8.
View in:
PubMed
Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma. Neuro Oncol. 2015 Oct; 17(10):1344-55.
View in:
PubMed
Ethnicity, race, and socioeconomic status influence incidence of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2015 Jun; 62(6):982-7.
View in:
PubMed
Prospective enterprise-level molecular genotyping of a cohort of cancer patients. J Mol Diagn. 2014 Nov; 16(6):660-72.
View in:
PubMed
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med. 2014 Jun; 20(6):682-8.
View in:
PubMed
Physicians' attitudes about multiplex tumor genomic testing. J Clin Oncol. 2014 May 01; 32(13):1317-23.
View in:
PubMed
Somatic activating ARAF mutations in Langerhans cell histiocytosis. Blood. 2014 May 15; 123(20):3152-5.
View in:
PubMed
Novel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma. PLoS One. 2013; 8(6):e66982.
View in:
PubMed
BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate. AJP Rep. 2013 Oct; 3(2):63-6.
View in:
PubMed
Pathogenesis of Langerhans cell histiocytosis. Annu Rev Pathol. 2013 Jan 24; 8:1-20.
View in:
PubMed
Recent advances in the understanding of Langerhans cell histiocytosis. Br J Haematol. 2012 Jan; 156(2):163-72.
View in:
PubMed
Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010 Sep 16; 116(11):1919-23.
View in:
PubMed
The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo. J Immunol. 2010 Jun 01; 184(11):6114-23.
View in:
PubMed
Where the confusion began: cloning the first chemokine receptors. J Immunol. 2009 Sep 01; 183(5):2893-4.
View in:
PubMed
Langerhans cell histiocytosis: malignancy or inflammatory disorder doing a great job of imitating one? Dis Model Mech. 2009 Sep-Oct; 2(9-10):436-9.
View in:
PubMed
RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma. Blood. 2009 Jul 16; 114(3):619-29.
View in:
PubMed
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma. Blood. 2009 Jun 25; 113(26):6669-80.
View in:
PubMed
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood. 2009 Apr 30; 113(18):4341-51.
View in:
PubMed
microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia. Blood. 2009 Apr 30; 113(18):4391-402.
View in:
PubMed
Inhibition of MCP-1/CCR2 signaling does not inhibit intimal proliferation in a mouse aortic transplant model. J Vasc Res. 2008; 45(6):538-46.
View in:
PubMed
Innocents abroad: regulating where naive T cells go. Nat Immunol. 2008 Mar; 9(3):233-5.
View in:
PubMed
Monocyte chemoattractant protein-1 is a pathogenic component in a model for a hereditary peripheral neuropathy. Mol Cell Neurosci. 2008 Feb; 37(2):359-66.
View in:
PubMed
Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1. Am J Hematol. 2008 Feb; 83(2):116-21.
View in:
PubMed
Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes. 2007 Sep; 56(9):2242-50.
View in:
PubMed
Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation. 2007 Feb 06; 115(5):584-92.
View in:
PubMed
Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia. 2007 Feb; 50(2):471-80.
View in:
PubMed
The chemokine decoy receptor M3 blocks CC chemokine ligand 2 and CXC chemokine ligand 13 function in vivo. J Immunol. 2006 Nov 15; 177(10):7296-302.
View in:
PubMed
Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells. Am J Physiol Gastrointest Liver Physiol. 2006 Nov; 291(5):G803-11.
View in:
PubMed
Release the hounds! A chemokine elicits monocytes from bone marrow. Nat Immunol. 2006 Mar; 7(3):230-2.
View in:
PubMed
Monocyte recruitment in venous thrombus resolution. J Vasc Surg. 2006 Mar; 43(3):601-8.
View in:
PubMed
Inflammatory chemokines in cancer growth and progression. Eur J Cancer. 2006 Apr; 42(6):760-7.
View in:
PubMed
The chemokine CCL2 is required for control of murine gastric Salmonella enterica infection. Infect Immun. 2005 Oct; 73(10):6514-22.
View in:
PubMed
CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture. J Immunol. 2005 May 01; 174(9):5856-63.
View in:
PubMed
Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice. FASEB J. 2005 May; 19(7):761-72.
View in:
PubMed
The effect of MCP-1 depletion on chemokine and chemokine-related gene expression: evidence for a complex network in acute inflammation. Cytokine. 2005 Apr 21; 30(2):64-71.
View in:
PubMed
CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res. 2005 Apr 29; 96(8):881-9.
View in:
PubMed
Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3. Circ Res. 2005 Mar 18; 96(5):576-82.
View in:
PubMed
Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood. 2005 Jun 01; 105(11):4308-13.
View in:
PubMed
The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol. 2004 Dec; 165(6):2157-66.
View in:
PubMed
Differential roles of CCL2 and CCR2 in host defense to coronavirus infection. Virology. 2004 Nov 24; 329(2):251-60.
View in:
PubMed
Aspergillus antigen induces robust Th2 cytokine production, inflammation, airway hyperreactivity and fibrosis in the absence of MCP-1 or CCR2. Respir Res. 2004 Sep 15; 5:12.
View in:
PubMed
CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol. 2004 Jun; 14(3):149-54.
View in:
PubMed
Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell. 2004 Apr 16; 117(2):239-51.
View in:
PubMed
MCP-1-dependent signaling in CCR2(-/-) aortic smooth muscle cells. J Leukoc Biol. 2004 Jun; 75(6):1079-85.
View in:
PubMed
Chemokine-based pathogenetic mechanisms in cancer. Novartis Found Symp. 2004; 256:29-41; discussion 41-52, 266-9.
View in:
PubMed
Chemokine influences on adaptive immunity and malignancies of the immune system. Ernst Schering Res Found Workshop. 2004; (45):11-30.
View in:
PubMed
Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. J Immunol. 2003 Dec 15; 171(12):6929-35.
View in:
PubMed
Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity. 2003 Dec; 19(6):891-901.
View in:
PubMed
Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells. Int J Cancer. 2003 Nov 10; 107(3):407-15.
View in:
PubMed
MCP-1 deficiency is associated with reduced intimal hyperplasia after arterial injury. Biochem Biophys Res Commun. 2003 Oct 24; 310(3):936-42.
View in:
PubMed
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med. 2003 Nov; 9(11):1390-7.
View in:
PubMed
Post-BMT lung injury occurs independently of the expression of CCL2 or its receptor, CCR2, on host cells. Am J Physiol Lung Cell Mol Physiol. 2004 Feb; 286(2):L284-92.
View in:
PubMed
CC chemokine ligand 2 and its receptor regulate mucosal production of IL-12 and TGF-beta in high dose oral tolerance. J Immunol. 2003 Oct 01; 171(7):3560-7.
View in:
PubMed
DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras. Oncogene. 2003 Jul 24; 22(30):4723-33.
View in:
PubMed
Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation. 2003 Jun; 10(3-4):247-57.
View in:
PubMed
Absence of CC chemokine ligand 2 results in an altered Th1/Th2 cytokine balance and failure to expel Trichuris muris infection. J Immunol. 2003 May 01; 170(9):4693-700.
View in:
PubMed
Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis. Blood. 2003 Apr 01; 101(7):2473-5.
View in:
PubMed
Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice. J Neurosci. 2002 Dec 15; 22(24):10633-42.
View in:
PubMed
Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res. 2002 Nov 01; 62(21):6304-11.
View in:
PubMed
Ccr2 regulates the level of MCP-1/CCL2 in vitro and at inflammatory sites and controls T cell activation in response to alloantigen. Cytokine. 2002 May 21; 18(4):184-90.
View in:
PubMed
MCP-1 expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 2002 May; 43(5):1493-8.
View in:
PubMed
A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan. J Immunol. 2001 Dec 01; 167(11):6576-82.
View in:
PubMed
Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med. 2001 Nov 05; 194(9):1361-73.
View in:
PubMed
Chemokines and atherosclerosis: what Adam Smith has to say about vascular disease. J Clin Invest. 2001 Nov; 108(9):1269-71.
View in:
PubMed
Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice. Am J Pathol. 2001 Aug; 159(2):457-63.
View in:
PubMed
A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer. Clin Cancer Res. 2001 Jun; 7(6):1590-9.
View in:
PubMed
If it's Tuesday, this must be a Belgian chemokine. Blood. 2001 Apr 15; 97(8):2193.
View in:
PubMed
Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med. 2001 Mar 19; 193(6):713-26.
View in:
PubMed
Chemokines and disease. Nat Immunol. 2001 Feb; 2(2):108-15.
View in:
PubMed
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature. 2000 Mar 23; 404(6776):407-11.
View in:
PubMed
The physiology of p16(INK4A)-mediated G1 proliferative arrest. Cell Biochem Biophys. 2000; 33(2):189-97.
View in:
PubMed
Targeted expression of chemokines in vivo. Methods Mol Biol. 2000; 138:243-51.
View in:
PubMed
Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med. 1999 Dec 20; 190(12):1813-24.
View in:
PubMed
Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines. Clin Cancer Res. 1999 Oct; 5(10):2925-38.
View in:
PubMed
Physiological coreceptor use by dual-tropic HIV-1: one plus one equals one. J Clin Invest. 1999 Sep; 104(5):531-2.
View in:
PubMed
Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med. 1999 Jul; 5(7):828-31.
View in:
PubMed
Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 1999 Jun; 19(6):1518-25.
View in:
PubMed
MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest. 1999 Mar; 103(6):773-8.
View in:
PubMed
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility. Oncogene. 1999 Jan 07; 18(1):67-77.
View in:
PubMed
Monocyte chemoattractant protein-1. Chem Immunol. 1999; 72:7-29.
View in:
PubMed
Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest. 1999 Jan; 103(1):73-80.
View in:
PubMed
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 1998 Aug; 2(2):275-81.
View in:
PubMed
Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med. 1998 Feb 16; 187(4):601-8.
View in:
PubMed
p16INK4A participates in a G1 arrest checkpoint in response to DNA damage. Mol Cell Biol. 1998 Jan; 18(1):378-87.
View in:
PubMed
Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J Biol Chem. 1997 Nov 07; 272(45):28568-73.
View in:
PubMed
In vivo properties of monocyte chemoattractant protein-1. J Leukoc Biol. 1997 Nov; 62(5):577-80.
View in:
PubMed
Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors. J Clin Endocrinol Metab. 1997 Sep; 82(9):3025-8.
View in:
PubMed
Chemokines. Blood. 1997 Aug 01; 90(3):909-28.
View in:
PubMed
Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. J Immunol. 1997 Jul 01; 159(1):401-8.
View in:
PubMed
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice. J Am Soc Nephrol. 1997 May; 8(5):720-9.
View in:
PubMed
MCP-1-mediated chemotaxis requires activation of non-overlapping signal transduction pathways. J Leukoc Biol. 1997 Apr; 61(4):529-32.
View in:
PubMed
Human fibroblasts express functional IL-2 receptors formed by the IL-2R alpha- and beta-chain subunits: association of IL-2 binding with secretion of the monocyte chemoattractant protein-1. J Immunol. 1996 Jul 15; 157(2):851-7.
View in:
PubMed
The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 1996 Jun 28; 85(7):1135-48.
View in:
PubMed
Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today. 1996 May; 2(5):198-204.
View in:
PubMed
p16INK4A as a human tumor suppressor. Biochim Biophys Acta. 1996 Mar 18; 1242(3):165-9.
View in:
PubMed
High level expression of human MCP-1 using the LCR/MEL expression system. Protein Expr Purif. 1996 Mar; 7(2):173-82.
View in:
PubMed
Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res. 1995 Dec 15; 55(24):6200-9.
View in:
PubMed
High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol. 1995 Nov 15; 155(10):4838-43.
View in:
PubMed
Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors. Cancer Immunol Immunother. 1995 Oct; 41(4):227-35.
View in:
PubMed
A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer. Mol Cell Biol. 1995 Sep; 15(9):4851-5.
View in:
PubMed
A novel p16INK4A transcript. Cancer Res. 1995 Jul 15; 55(14):2995-7.
View in:
PubMed
Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res. 1995 Feb 01; 55(3):505-9.
View in:
PubMed
Serologic analysis of the mouse beta chemokine JE/monocyte chemoattractant protein-1. J Immunol. 1994 Oct 15; 153(8):3708-16.
View in:
PubMed
Monocyte chemoattractant protein-1 gene is expressed in activated neutrophils and retinoic acid-induced human myeloid cell lines. Blood. 1994 Oct 15; 84(8):2776-83.
View in:
PubMed
Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. J Biol Chem. 1994 Jun 03; 269(22):15918-24.
View in:
PubMed
Biochemical and biologic characterization of murine monocyte chemoattractant protein-1. Identification of two functional domains. J Immunol. 1994 Apr 01; 152(7):3541-9.
View in:
PubMed
MCP-1 expression by rat type II alveolar epithelial cells in primary culture. J Immunol. 1993 May 15; 150(10):4561-70.
View in:
PubMed
"Oh, no. Not another cytokine."--MCP-1 and respiratory disease. Am J Respir Cell Mol Biol. 1992 Aug; 7(2):126-7.
View in:
PubMed
JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ Res. 1992 Feb; 70(2):314-25.
View in:
PubMed
Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am J Physiol. 1991 Dec; 261(6 Pt 2):F1095-101.
View in:
PubMed
JE/MCP-1: an early-response gene encodes a monocyte-specific cytokine. Cancer Cells. 1991 Dec; 3(12):517-24.
View in:
PubMed
In vivo and in vitro inhibition of JE gene expression by glucocorticoids. J Biol Chem. 1991 Nov 25; 266(33):22375-9.
View in:
PubMed
Human keratinocyte growth-promoting activity on the surface of fibroblasts. J Cell Physiol. 1991 Oct; 149(1):110-6.
View in:
PubMed
Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood. 1991 Aug 15; 78(4):1112-6.
View in:
PubMed
Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am J Pathol. 1991 Jun; 138(6):1315-9.
View in:
PubMed
Monocyte chemotactic protein gene expression by cytokine-treated human retinal pigment epithelial cells. Lab Invest. 1991 Jun; 64(6):819-25.
View in:
PubMed
Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol Cell Biol. 1991 Jun; 11(6):3125-31.
View in:
PubMed
Assignment of the human small inducible cytokine A2 gene, SCYA2 (encoding JE or MCP-1), to 17q11.2-12: evolutionary relatedness of cytokines clustered at the same locus. Genomics. 1991 Jun; 10(2):489-92.
View in:
PubMed
Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem. 1991 May 25; 266(15):9912-8.
View in:
PubMed
Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol. 1990 Jun; 136(6):1229-33.
View in:
PubMed
The human homolog of the JE gene encodes a monocyte secretory protein. Mol Cell Biol. 1989 Nov; 9(11):4687-95.
View in:
PubMed
Environment-dependent growth inhibition of human epidermal keratinocytes by recombinant human transforming growth factor-beta. J Cell Physiol. 1989 Jun; 139(3):455-62.
View in:
PubMed
Evidence for a novel signal transduction pathway activated by platelet-derived growth factor and by double-stranded RNA. Mol Cell Biol. 1989 Apr; 9(4):1705-13.
View in:
PubMed
Serum-inducible genes. Adv Cancer Res. 1989; 53:1-32.
View in:
PubMed
Platelet-derived growth factor regulates glucose transporter expression. J Biol Chem. 1988 Nov 15; 263(32):16523-6.
View in:
PubMed
Comparison of fibroblast and T-cell activation genes. Cell Immunol. 1988 Sep; 115(2):481-3.
View in:
PubMed
Association of food frequency questionnaire estimates of vitamin A intake with serum vitamin A levels. Am J Epidemiol. 1988 Sep; 128(3):645-54.
View in:
PubMed
Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc Natl Acad Sci U S A. 1988 Jun; 85(11):3738-42.
View in:
PubMed
Regulation of c-myc and c-fos proto-oncogene expression by animal cell growth factors. In Vitro Cell Dev Biol. 1988 Feb; 24(2):81-4.
View in:
PubMed
Molecular regulation of growth control: implications for wound healing. Prog Clin Biol Res. 1988; 266:19-22.
View in:
PubMed
Platelet-derived growth factor generates at least two distinct intracellular signals that modulate gene expression. Cold Spring Harb Symp Quant Biol. 1988; 53 Pt 1:531-6.
View in:
PubMed
A cell-cycle constraint on the regulation of gene expression by platelet-derived growth factor. Science. 1987 Nov 27; 238(4831):1269-71.
View in:
PubMed
Differential colony hybridization: molecular cloning from a zero data base. Methods Enzymol. 1987; 147:64-85.
View in:
PubMed
Preliminary characterization of the proteoglycans in the substrate adhesion sites of normal and virus-transformed murine cells. Biochemistry. 1979 Dec 11; 18(25):5621-9.
View in:
PubMed
Fibronectin and proteoglycans as determinants of cell-substratum adhesion. J Supramol Struct. 1979; 11(3):401-27.
View in:
PubMed
Two functionally distinct pools of glycosaminoglycan in the substrate adhesion site of murine cells. J Cell Biol. 1978 Dec; 79(3):788-801.
View in:
PubMed